Davis Capital Management’s PTC Therapeutics PTCT Stock Holding History

Davis Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$408	Buy	+5	New	+$361	﹤0.01%	652

Other funds holding PTCT

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Davis Capital Management's PTCT Position: Q2 2026 in Review

Davis Capital Management opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 5 shares worth $408. The stake represents ﹤0.01% of the portfolio and ranks #652 among its holdings.

69 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Davis Capital Management held 5 shares of PTC Therapeutics worth $408 as of Q2 2026.
PTC Therapeutics was a new Davis Capital Management position in Q2 2026.
PTC Therapeutics made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #652 holding.
69 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.